Literature DB >> 23758239

Treating iron overload.

Clara Camaschella1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23758239     DOI： 10.1056/NEJMcibr1304338

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

Review 1.  The liver: conductor of systemic iron balance.

Authors:  Delphine Meynard; Jodie L Babitt; Herbert Y Lin
Journal:  Blood       Date:  2013-11-07       Impact factor: 22.113

2.  Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major?

Authors:  Domenico Girelli; Fabiana Busti
Journal:  Haematologica       Date:  2020-07       Impact factor: 9.941

3.  Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.

Authors:  Morgan E Preziosi; Sucha Singh; Erika V Valore; Grace Jung; Branimir Popovic; Minakshi Poddar; Shanmugam Nagarajan; Tomas Ganz; Satdarshan P Monga
Journal:  J Hepatol       Date:  2017-03-22       Impact factor: 25.083

Review 4.  Protecting the mitochondrial powerhouse.

Authors:  Morten Scheibye-Knudsen; Evandro F Fang; Deborah L Croteau; David M Wilson; Vilhelm A Bohr
Journal:  Trends Cell Biol       Date:  2014-12-11       Impact factor: 20.808

Review 5.  Pathogenesis of liver cirrhosis.

Authors:  Wen-Ce Zhou; Quan-Bao Zhang; Liang Qiao
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 6.  Physiology of iron metabolism.

Authors:  Sophie Waldvogel-Abramowski; Gérard Waeber; Christoph Gassner; Andreas Buser; Beat M Frey; Bernard Favrat; Jean-Daniel Tissot
Journal:  Transfus Med Hemother       Date:  2014-05-12       Impact factor: 3.747

7.  The European Hematology Association Roadmap for European Hematology Research: a consensus document.

Authors:  Andreas Engert; Carlo Balduini; Anneke Brand; Bertrand Coiffier; Catherine Cordonnier; Hartmut Döhner; Thom Duyvené de Wit; Sabine Eichinger; Willem Fibbe; Tony Green; Fleur de Haas; Achille Iolascon; Thierry Jaffredo; Francesco Rodeghiero; Gilles Salles; Jan Jacob Schuringa
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

Review 8.  Hepcidin in the diagnosis of iron disorders.

Authors:  Domenico Girelli; Elizabeta Nemeth; Dorine W Swinkels
Journal:  Blood       Date:  2016-04-04       Impact factor: 22.113

9.  Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia.

Authors:  João Arezes; Niall Foy; Kirsty McHugh; Doris Quinkert; Susan Benard; Anagha Sawant; Joe N Frost; Andrew E Armitage; Sant-Rayn Pasricha; Pei Jin Lim; May S Tam; Edward Lavallie; Debra D Pittman; Orla Cunningham; Matthew Lambert; John E Murphy; Simon J Draper; Reema Jasuja; Hal Drakesmith
Journal:  Blood       Date:  2020-02-20       Impact factor: 25.476

Review 10.  Labile iron in cells and body fluids: physiology, pathology, and pharmacology.

Authors:  Zvi Ioav Cabantchik
Journal:  Front Pharmacol       Date:  2014-03-13       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.